Topical fibroblast growth factor‐2 for treatment of chronic tympanic membrane perforations
Abstract
To determine the efficacy of fibroblast growth factor‐2 (FGF‐2) in treating chronic nonhealing tympanic membrane (TM) perforations.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 14, 2020
- Source ID
- 10.1002/lio2.395
Entities
People
- Alicia Quesnel
- Amy Quinkert
- Camden P. Bay
- D Bradley Welling
- Daniel J. Lee
- David H. Jung
- Dunia E Abdul-Aziz
- Edina Shu
- Felipe Santos
- Konstantina M. Stankovic
Organizations
- Harvard Catalyst
- Harvard Medical School
- Harvard University
- National Center for Advancing Translational Sciences
- National Institutes of Health
- United States Department of Defense